October 5, 2020: CCX Media visited Francis Medical to interview President and CEO Mike Kujak, and get an inside look at how Francis Medical is thriving and moving forward during the COVID-19 pandemic. This two-minute video includes recent news about a $4M investment by Coloplast
This video demonstrates how water vapor therapy will provide a revolutionary new prostate cancer treatment that is tough on prostate cancer yet gentle on patients
June 18, 2020: CCX Media visited Francis Medical for exclusive interviews with CEO and President, Mike Kujak, and Founder and CTO, Michael Hoey. Their two-minute video includes an explanation of our revolutionary water vapor therapy, as well as plans for the future, including our VAPOR 1 clinical study
The Vanquish® Water Vapor Ablation System is indicated for the thermal ablation of targeted prostate tissue via a transurethral approach. The FDA has not evaluated the Vanquish System for the treatment of any disease, including prostate cancer, or evaluated the Vanquish System for any long-term prostate cancer treatment outcomes.
Federal law (USA) restricts this device to sale by or on the order of a physician.
Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.